- Home
- EEA vs ALPS Comparison
EEA vs ALPS Comparison
Compare EEA & ALPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | EEA | ALPS |
|---|---|---|
| Founded | 1986 | 2017 |
| Country | Germany | Malaysia |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | |
| Sector | Finance | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 70.2M | 66.6M |
| IPO Year | N/A | 2024 |
Fundamental Metrics
Financial Performance| Metric | EEA | ALPS |
|---|---|---|
| Price | $10.56 | $1.17 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 27.6K | ★ 58.8K |
| Earning Date | 01-01-0001 | 07-24-2026 |
| Dividend Yield | ★ 1.92% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.62 | $0.23 |
| 52 Week High | $11.43 | $2.02 |
Technical Indicators
Market Signals| Indicator | EEA | ALPS |
|---|---|---|
| Relative Strength Index (RSI) | 58.23 | 69.17 |
| Support Level | $10.42 | $0.81 |
| Resistance Level | $11.13 | $1.39 |
| Average True Range (ATR) | 0.18 | 0.11 |
| MACD | 0.05 | 0.10 |
| Stochastic Oscillator | 67.16 | 53.26 |
Price Performance
Historical ComparisonAbout EEA The European Equity Fund Inc.
European Equity Fund, Inc / MD is a United States-based diversified, closed-end management investment company. The fund seeks long-term capital appreciation through investment in equity and equity securities of issuers domiciled in Europe. Its portfolio of investments consists of different sectors such as industrials, financials, healthcare, consumer discretionary, materials, consumer staples, information technology, and other sectors.
About ALPS ALPS Group Inc Ordinary Share
ALPS Group Inc is an investment holding company involved in research and development, including stem cell and biotechnology-related business, and investing and managing businesses such as health and beauty centres and medical centres. The Company operates through Medical and Wellness, Life Science and Others segments. Medical and Wellness generates maximum revenue from non-surgical aesthetic services, surgical aesthetic services, medical consultation, health screenings, cellular therapy and research, and COVID-19 testing. Life Science provides whole-genome sequencing and pharmacogenomics, while Others comprises investment holding and provision of management services. The Company generates revenue in Malaysia.